De-Kuang DK Hwang, MD, PhD

De-Kuang DK Hwang, MD, PhD

Department of Ophthalmology, Taipei Veterans General Hospital
No.201, Sec. 2, Shipai Rd.,
Beitou District, Taipei City,
Taipei, 11217
Taiwan, ROC (Republic of China) map

+88 622-875-7325 office


Professional Affiliations

Academic Appointments
  • Council Member, Taiwan Retinal Society & Taiwan Ocular Inflammation Society
  • Associate professor, National Yang-Ming Chiao Tung University/ Taipei/ Taiwan
Hospital Appointments
  • Division director, Uveitis service, Department of Ophthalmology, Taipei Veterans General Hospital, Taipei/ Taiwan/ 2024

Education and Training

Retinal fellowship
Taipei Veterans General Hospital, Taipei, Taiwan

Biography

Dr. Hwang was born in Taipei, Taiwan. After completing his residency and clinical fellowship at Taipei Veterans General Hospital, he pursued further training as an international postdoctoral scholar and clinical observer in uveitis and retina at Kyorin University Hospital, the University of Tokyo Hospital, and the Francis I. Proctor Foundation, University of California, San Francisco (UCSF).
Dr. Hwang specializes clinically in uveitis and retinal diseases (both medical and surgical) and currently serves as Section Chief of the Uveitis and Oculoplasty Division in the Department of Ophthalmology at Taipei Veterans General Hospital. He is also the Supervisor of the Taiwan Retina Society and a Trustee of the Taiwan Ocular Inflammation Society. In addition, he is an Associate Professor of Ophthalmology at National Yang Ming Chiao Tung University.
Dr. Hwang holds a PhD in Public Health and Epidemiology. He has published extensively on topics including the application of precision medicine in uveitis and retinal diseases, real-world pharmacological treatments for macular diseases, ophthalmic epidemiology, big-data analysis, gene analysis, and artificial intelligence. He has contributed to the development of various local and international clinical consensus statements and recommendations for the management of uveitis and retinal diseases. He has also served as a Principal Investigator or Sub-Investigator for numerous international clinical trials.